Skip to main content.

specialty drugs

Picture of Pauline Bartolone

The secretive world of pharmaceutical pricing is mired in opacity. To investigate how pricey drugs are impacting California’s budget, reporter Pauline Bartolone found she had to be creative, flexible and persistent in her data sleuthing.

Picture of Pauline Bartolone

What looks like a straightforward framework to protect California’s budget from escalating drug costs has policy experts perplexed, and potential allies on the sidelines.

Picture of Pauline Bartolone

Despite recent cost-cutting measures, California’s spending on pharmaceuticals has gone up, and so has the number of pricey drugs it is covering. It’s not clear state agencies have the means to balance drug cost pressures with the best interests of patients, taxpayers and public health.

Picture of Pauline Bartolone

The specialty drug Orkambi, for cystic fibrosis, has a sticker price of $259,000 per year. What's driving these astronomical costs for specialty drugs? And can California's budget cope?

Announcements

The Center for Health Journalism is dedicated to supporting journalists covering two of the biggest stories of our time — the twin pandemics of COVID-19 and systemic racism and inequities in America. We provide reporters with intensive training instituteswebinars and tips about craft and content and are providing deep and sustained support for reporters and their newsrooms in this historic and difficult moment. You can donate through the USC web portal at this link. Pressed for time? You can also text to donate! No amount is too small; just send a text to 41-444 and type the message CHJ for further instructions.

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth